医学临床研究
  2025年4月5日 星期六           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2021, Vol. 38 Issue (12): 1787-1790    DOI: 10.3969/j.issn.1671-7171.2021.12.009
  论著 本期目录 | 过刊浏览 | 高级检索 |
载药微球肝动脉栓塞与手术切除治疗Ⅱb期原发性肝癌的近远期疗效比较
王松, 王文超*, 杨俊驰, 李阿建, 李越
上海市杨浦区中心医院(同济大学附属杨浦医院),上海 200090
Effect of Drug-eluting Beads Transcatheter Arterial Chemoembolization and Surgical Resection on Short-term and Long-term Efficacy of Stage Ⅱb Primary Liver Cancer
WANG Song, WANG Wen-chao, YANG Jun-chi, et al
Shanghai Yangpu District Central Hospital(Yangpu Hospital,Tongji University),Shanghai 200090
全文: PDF (1771 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】比较载药微球肝动脉栓塞(TACE)与手术切除治疗Ⅱb期原发性肝癌的近远期疗效。【方法】本院收治的68例首诊Ⅱb期原发性肝癌患者随机分为A组和B组,各34例。B组进行手术切除,A组接受CalliSpheres聚乙烯醇栓塞微球经导管动脉化疗栓塞(DEB-TACE),两组复发后均接受TACE治疗。比较两组无进展生存期(DFS)、总生存期(OS)、治疗前后血生化资料、并发症情况和近期疗效。【结果】两组治疗后1个月和3个月的客观缓解率,疾病控制率相比较差异均无显著性(P>0.05)。两组治疗3个月和治疗6个月后AFP、TBIL、AST、ALT、VEGF、bFGF均较治疗前降低(P<0.05);治疗3个月两组ALB较治疗前增高(P<0.05)。治疗后2年内两组平均累积TACE治疗次数比较差异无显著性(P>0.05)。两组并发症发生率比较差异无显著性(P>0.05)。A组和B组累积DFS率、累积OS率比较差异均无显著性(P>0.05)。【结论】DEB-TACE治疗Ⅱb期原发性肝癌效果显著,与手术切除的效果及预后相当。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 肝肿瘤/外科学栓塞, 治疗性肝动脉微球体药物载体治疗结果    
Abstract:【Objective】To compare the near-and long-term efficacy of drug-loaded microspheres through transcatheter hepatic arterial embolization (TACE) and surgical resection for stage Ⅱb primary liver cancer. 【Methods】A total of 68 patients with primary liver cancer of stage Ⅱb were random divided into groups A and B, with 34 cases each. The group B underwent surgical resection, while group A received CalliSpheres drug-eluting beads transarterial chemoembolization (DEB-TACE). Both groups received transarterial chemoembolization after relapse. The progression-free survival (DFS), overall survival (OS), blood biochemical data before and after treatment, complications, and short-term efficacy were compared between the two groups. 【Results】There were no significant differences in objective remission rate and the disease control rate at 1 month and at 3 months after treatment between the two groups (P>0.05). Compared with before treatment, the levels of VEGF, bFGF, AFP, TBIL, AST and ALT in both groups decreased after 3 months and after 6 months of treatment(P<0.05), while ALB increased after 3 months of treatment(P<0.05). There was no significant difference in the average cumulative number of TACE treatments between the two groups within 2 years after treatment (P>0.05). There was no significant difference in the incidence of complications between the two groups (P>0.05). There were no significant differences in cumulative DFS rate and cumulative OS rate between group A and group B (P>0.05). 【Conclusion】DEB-TACE is effective in the treatment of stage Ⅱb primary liver cancer, which is equivalent to the effect and prognosis of surgical resection, while DEB-TACE can reduce the number of TACE treatments and reduce the cost of hospitalization.
Key wordsLiver Neoplasms /SU    Embolization, Therapeutic    Microspheres    Drug Carriers    Treatment Outcome
收稿日期: 2020-11-04     
中图分类号:  R735.7  
通讯作者: *E-mail:wangwenchaosmmu@163.com   
引用本文:   
王松, 王文超, 杨俊驰, 李阿建, 李越. 载药微球肝动脉栓塞与手术切除治疗Ⅱb期原发性肝癌的近远期疗效比较[J]. 医学临床研究, 2021, 38(12): 1787-1790.
WANG Song, WANG Wen-chao, YANG Jun-chi, et al. Effect of Drug-eluting Beads Transcatheter Arterial Chemoembolization and Surgical Resection on Short-term and Long-term Efficacy of Stage Ⅱb Primary Liver Cancer. JOURNAL OF CLINICAL RESEARCH, 2021, 38(12): 1787-1790.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2021.12.009     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2021/V38/I12/1787
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn